LymphedemaV1, Ncbi, Merge, bibRecord, 006755

Prospective multicentre observational study of lymphedema therapy: POLIT study.

Identifieur interne : 006755 ( Ncbi/Merge ); précédent : 006754; suivant : 006756

Prospective multicentre observational study of lymphedema therapy: POLIT study.

Auteurs : I. Quéré [France] ; E. Presles [France] ; M. Coupé [France] ; S. Vignes [France] ; L. Vaillant [France] ; D. Eveno [France] ; S. Laporte [France] ; A. Leizorovicz [France]

Source :

Journal des maladies vasculaires [ 2214-8116 ] ; 2014.

RBID : pubmed:24931830

Descripteurs français

KwdFr :
- Adulte, Adulte d'âge moyen, Bandages de compression (effets indésirables), Bras (anatomopathologie), Femelle, Humains, Jambe (anatomopathologie), Lymphadénectomie (effets indésirables), Lymphoedème (), Lymphoedème (anatomopathologie), Lymphoedème (rééducation et réadaptation), Lymphoedème (étiologie), Massage, Résultat thérapeutique, Sujet âgé, Taille d'organe, Traitement par les exercices physiques, Tumeurs du sein (), Études de suivi, Études prospectives.
MESH :
- anatomopathologie : Bras, Jambe, Lymphoedème.
- effets indésirables : Bandages de compression, Lymphadénectomie.
- rééducation et réadaptation : Lymphoedème.
- étiologie : Lymphoedème.
- Adulte, Adulte d'âge moyen, Femelle, Humains, Lymphoedème, Massage, Résultat thérapeutique, Sujet âgé, Taille d'organe, Traitement par les exercices physiques, Tumeurs du sein, Études de suivi, Études prospectives.

English descriptors

KwdEn :
- Adult, Aged, Arm (pathology), Breast Neoplasms (surgery), Compression Bandages (adverse effects), Exercise Therapy, Female, Follow-Up Studies, Humans, Leg (pathology), Lymph Node Excision (adverse effects), Lymphedema (etiology), Lymphedema (pathology), Lymphedema (rehabilitation), Lymphedema (therapy), Massage, Middle Aged, Organ Size, Prospective Studies, Treatment Outcome.
MESH :
- adverse effects : Compression Bandages, Lymph Node Excision.
- etiology : Lymphedema.
- pathology : Arm, Leg, Lymphedema.
- rehabilitation : Lymphedema.
- surgery : Breast Neoplasms.
- therapy : Lymphedema.
- Adult, Aged, Exercise Therapy, Female, Follow-Up Studies, Humans, Massage, Middle Aged, Organ Size, Prospective Studies, Treatment Outcome.

Abstract

Lymphedema treatment is based on Decongestive Lymphedema Therapy (DLT) with an intensive phase followed by a long-term maintenance phase. This study aimed to observe volume variation over the intensive phase and 6 months later.

DOI: 10.1016/j.jmv.2014.05.004
PubMed: 24931830

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001487
to stream PubMed, to step Curation: 001487
to stream PubMed, to step Checkpoint: 001487

Links to Exploration step

pubmed:24931830

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prospective multicentre observational study of lymphedema therapy: POLIT study.</title>
<author><name sortKey="Quere, I" sort="Quere, I" uniqKey="Quere I" first="I" last="Quéré">I. Quéré</name>
<affiliation wicri:level="4"><nlm:affiliation>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier, France. Electronic address: i-quere@chu-montpellier.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier</wicri:regionArea>
<wicri:noRegion>34295 cedex 5 Montpellier</wicri:noRegion>
<orgName type="university">Université Montpellier 1</orgName>
<placeName><settlement type="city">Montpellier</settlement>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Presles, E" sort="Presles, E" uniqKey="Presles E" first="E" last="Presles">E. Presles</name>
<affiliation wicri:level="1"><nlm:affiliation>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne</wicri:regionArea>
<wicri:noRegion>42055 Saint-Étienne</wicri:noRegion>
<wicri:noRegion>42055 Saint-Étienne</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Coupe, M" sort="Coupe, M" uniqKey="Coupe M" first="M" last="Coupé">M. Coupé</name>
<affiliation wicri:level="4"><nlm:affiliation>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier</wicri:regionArea>
<wicri:noRegion>34295 cedex 5 Montpellier</wicri:noRegion>
<orgName type="university">Université Montpellier 1</orgName>
<placeName><settlement type="city">Montpellier</settlement>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vignes, S" sort="Vignes, S" uniqKey="Vignes S" first="S" last="Vignes">S. Vignes</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Lymphology, Cognacq-Jay Hospital, 75015 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Lymphology, Cognacq-Jay Hospital, 75015 Paris</wicri:regionArea>
<wicri:noRegion>75015 Paris</wicri:noRegion>
<placeName><settlement type="city">Paris</settlement>
<region type="région" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vaillant, L" sort="Vaillant, L" uniqKey="Vaillant L" first="L" last="Vaillant">L. Vaillant</name>
<affiliation wicri:level="1"><nlm:affiliation>Université François-Rabelais, 10, boulevard Tonnellé, BP 3223, 37032 Tours cedex 1, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université François-Rabelais, 10, boulevard Tonnellé, BP 3223, 37032 Tours cedex 1</wicri:regionArea>
<wicri:noRegion>37032 Tours cedex 1</wicri:noRegion>
<wicri:noRegion>37032 Tours cedex 1</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Eveno, D" sort="Eveno, D" uniqKey="Eveno D" first="D" last="Eveno">D. Eveno</name>
<affiliation wicri:level="1"><nlm:affiliation>Service de médecine interne, Hôtel-Dieu, 44093 Nantes cedex 01, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de médecine interne, Hôtel-Dieu, 44093 Nantes cedex 01</wicri:regionArea>
<wicri:noRegion>44093 Nantes cedex 01</wicri:noRegion>
<wicri:noRegion>44093 Nantes cedex 01</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Laporte, S" sort="Laporte, S" uniqKey="Laporte S" first="S" last="Laporte">S. Laporte</name>
<affiliation wicri:level="1"><nlm:affiliation>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne, France; EA 3065, université Jean-Monnet, 42023 Saint-Étienne, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne, France; EA 3065, université Jean-Monnet, 42023 Saint-Étienne</wicri:regionArea>
<wicri:noRegion>42023 Saint-Étienne</wicri:noRegion>
<wicri:noRegion>42023 Saint-Étienne</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Leizorovicz, A" sort="Leizorovicz, A" uniqKey="Leizorovicz A" first="A" last="Leizorovicz">A. Leizorovicz</name>
<affiliation wicri:level="1"><nlm:affiliation>UMR 5558, CNRS Villeurbanne, université Claude-Bernard - Lyon 1, 69373 Lyon cedex 08, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>UMR 5558, CNRS Villeurbanne, université Claude-Bernard - Lyon 1, 69373 Lyon cedex 08</wicri:regionArea>
<wicri:noRegion>69373 Lyon cedex 08</wicri:noRegion>
<wicri:noRegion>69373 Lyon cedex 08</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24931830</idno>
<idno type="pmid">24931830</idno>
<idno type="doi">10.1016/j.jmv.2014.05.004</idno>
<idno type="wicri:Area/PubMed/Corpus">001487</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001487</idno>
<idno type="wicri:Area/PubMed/Curation">001487</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001487</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001487</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001487</idno>
<idno type="wicri:Area/Ncbi/Merge">006755</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Prospective multicentre observational study of lymphedema therapy: POLIT study.</title>
<author><name sortKey="Quere, I" sort="Quere, I" uniqKey="Quere I" first="I" last="Quéré">I. Quéré</name>
<affiliation wicri:level="4"><nlm:affiliation>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier, France. Electronic address: i-quere@chu-montpellier.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier</wicri:regionArea>
<placeName><region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">cedex 5 Montpellier</settlement>
<settlement type="city">Montpellier</settlement>
</placeName>
<orgName type="university">Université Montpellier 1</orgName>
</affiliation>
</author>
<author><name sortKey="Presles, E" sort="Presles, E" uniqKey="Presles E" first="E" last="Presles">E. Presles</name>
<affiliation wicri:level="1"><nlm:affiliation>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne</wicri:regionArea>
<wicri:noRegion>42055 Saint-Étienne</wicri:noRegion>
<wicri:noRegion>42055 Saint-Étienne</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Coupe, M" sort="Coupe, M" uniqKey="Coupe M" first="M" last="Coupé">M. Coupé</name>
<affiliation wicri:level="4"><nlm:affiliation>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier</wicri:regionArea>
<wicri:noRegion>34295 cedex 5 Montpellier</wicri:noRegion>
<orgName type="university">Université Montpellier 1</orgName>
<placeName><settlement type="city">Montpellier</settlement>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vignes, S" sort="Vignes, S" uniqKey="Vignes S" first="S" last="Vignes">S. Vignes</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Lymphology, Cognacq-Jay Hospital, 75015 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Lymphology, Cognacq-Jay Hospital, 75015 Paris</wicri:regionArea>
<wicri:noRegion>75015 Paris</wicri:noRegion>
<placeName><settlement type="city">Paris</settlement>
<region type="région" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vaillant, L" sort="Vaillant, L" uniqKey="Vaillant L" first="L" last="Vaillant">L. Vaillant</name>
<affiliation wicri:level="1"><nlm:affiliation>Université François-Rabelais, 10, boulevard Tonnellé, BP 3223, 37032 Tours cedex 1, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université François-Rabelais, 10, boulevard Tonnellé, BP 3223, 37032 Tours cedex 1</wicri:regionArea>
<wicri:noRegion>37032 Tours cedex 1</wicri:noRegion>
<wicri:noRegion>37032 Tours cedex 1</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Eveno, D" sort="Eveno, D" uniqKey="Eveno D" first="D" last="Eveno">D. Eveno</name>
<affiliation wicri:level="1"><nlm:affiliation>Service de médecine interne, Hôtel-Dieu, 44093 Nantes cedex 01, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de médecine interne, Hôtel-Dieu, 44093 Nantes cedex 01</wicri:regionArea>
<wicri:noRegion>44093 Nantes cedex 01</wicri:noRegion>
<wicri:noRegion>44093 Nantes cedex 01</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Laporte, S" sort="Laporte, S" uniqKey="Laporte S" first="S" last="Laporte">S. Laporte</name>
<affiliation wicri:level="1"><nlm:affiliation>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne, France; EA 3065, université Jean-Monnet, 42023 Saint-Étienne, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne, France; EA 3065, université Jean-Monnet, 42023 Saint-Étienne</wicri:regionArea>
<wicri:noRegion>42023 Saint-Étienne</wicri:noRegion>
<wicri:noRegion>42023 Saint-Étienne</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Leizorovicz, A" sort="Leizorovicz, A" uniqKey="Leizorovicz A" first="A" last="Leizorovicz">A. Leizorovicz</name>
<affiliation wicri:level="1"><nlm:affiliation>UMR 5558, CNRS Villeurbanne, université Claude-Bernard - Lyon 1, 69373 Lyon cedex 08, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>UMR 5558, CNRS Villeurbanne, université Claude-Bernard - Lyon 1, 69373 Lyon cedex 08</wicri:regionArea>
<wicri:noRegion>69373 Lyon cedex 08</wicri:noRegion>
<wicri:noRegion>69373 Lyon cedex 08</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal des maladies vasculaires</title>
<idno type="eISSN">2214-8116</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Arm (pathology)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Compression Bandages (adverse effects)</term>
<term>Exercise Therapy</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Leg (pathology)</term>
<term>Lymph Node Excision (adverse effects)</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (pathology)</term>
<term>Lymphedema (rehabilitation)</term>
<term>Lymphedema (therapy)</term>
<term>Massage</term>
<term>Middle Aged</term>
<term>Organ Size</term>
<term>Prospective Studies</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Bandages de compression (effets indésirables)</term>
<term>Bras (anatomopathologie)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jambe (anatomopathologie)</term>
<term>Lymphadénectomie (effets indésirables)</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (anatomopathologie)</term>
<term>Lymphoedème (rééducation et réadaptation)</term>
<term>Lymphoedème (étiologie)</term>
<term>Massage</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Taille d'organe</term>
<term>Traitement par les exercices physiques</term>
<term>Tumeurs du sein ()</term>
<term>Études de suivi</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Compression Bandages</term>
<term>Lymph Node Excision</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Bras</term>
<term>Jambe</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Bandages de compression</term>
<term>Lymphadénectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Arm</term>
<term>Leg</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="rééducation et réadaptation" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Exercise Therapy</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Massage</term>
<term>Middle Aged</term>
<term>Organ Size</term>
<term>Prospective Studies</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème</term>
<term>Massage</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Taille d'organe</term>
<term>Traitement par les exercices physiques</term>
<term>Tumeurs du sein</term>
<term>Études de suivi</term>
<term>Études prospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Lymphedema treatment is based on Decongestive Lymphedema Therapy (DLT) with an intensive phase followed by a long-term maintenance phase. This study aimed to observe volume variation over the intensive phase and 6 months later.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24931830</PMID>
<DateCreated><Year>2014</Year>
<Month>07</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>05</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>07</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2214-8116</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>39</Volume>
<Issue>4</Issue>
<PubDate><Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Journal des maladies vasculaires</Title>
<ISOAbbreviation>J Mal Vasc</ISOAbbreviation>
</Journal>
<ArticleTitle>Prospective multicentre observational study of lymphedema therapy: POLIT study.</ArticleTitle>
<Pagination><MedlinePgn>256-63</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jmv.2014.05.004</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0398-0499(14)00094-8</ELocationID>
<Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Lymphedema treatment is based on Decongestive Lymphedema Therapy (DLT) with an intensive phase followed by a long-term maintenance phase. This study aimed to observe volume variation over the intensive phase and 6 months later.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Prospective multicentre observational study of patients with unilateral lymphedema. The primary objective was to assess lymphedema volume variation between baseline, the end of intensive phase and 6 months later. Secondary objectives were to assess the frequency of heaviness limiting limb function and treatments safety predictors for volume reduction.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Three hundred and six patients (89.9% women; 59.9±14.3 years old) with upper/lower (n=184/122) limb lymphedema were included. At the end of the intensive phase, median excess lymphedema volume reduction was 31.0% (41.7-19.9) followed by a 16.5% (5.9-42.3) median increase over the 6-month maintenance period phase. Previous intensive treatment was the only significant predictor of this response. As compared to baseline, heaviness limiting limb use was much less frequently reported at the end of the reductive phase (75.5% versus 42.3% respectively), and was more frequent at the end of the maintenance phase (62.6%). The most frequent adverse events reported were skin redness and compression marks (18.4 and 15.7% of patients, respectively). Blisters requiring treatment stoppage were rare (1.4%).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Intensive phase decreases lymphedema volume and heaviness limiting limb function. The benefit is partially abolished after the first 6 months of maintenance. There is a need to consider how to provide optimal patient care for the long-term control of lymphedema.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Masson SAS. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Quéré</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier, France. Electronic address: i-quere@chu-montpellier.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Presles</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Coupé</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vignes</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Lymphology, Cognacq-Jay Hospital, 75015 Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vaillant</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Université François-Rabelais, 10, boulevard Tonnellé, BP 3223, 37032 Tours cedex 1, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Eveno</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Service de médecine interne, Hôtel-Dieu, 44093 Nantes cedex 01, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Laporte</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne, France; EA 3065, université Jean-Monnet, 42023 Saint-Étienne, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Leizorovicz</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>UMR 5558, CNRS Villeurbanne, université Claude-Bernard - Lyon 1, 69373 Lyon cedex 08, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>POLIT Study investigators</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D064888">Observational Study</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>06</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>J Mal Vasc</MedlineTA>
<NlmUniqueID>7707965</NlmUniqueID>
<ISSNLinking>0398-0499</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001132" MajorTopicYN="N">Arm</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058128" MajorTopicYN="Y">Compression Bandages</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005081" MajorTopicYN="Y">Exercise Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007866" MajorTopicYN="N">Leg</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008405" MajorTopicYN="Y">Massage</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bandage</Keyword>
<Keyword MajorTopicYN="N">Bandaging</Keyword>
<Keyword MajorTopicYN="N">Cancer</Keyword>
<Keyword MajorTopicYN="N">Compression</Keyword>
<Keyword MajorTopicYN="N">Decongestive therapy</Keyword>
<Keyword MajorTopicYN="N">Lymphedema</Keyword>
<Keyword MajorTopicYN="N">Lymphœdème</Keyword>
<Keyword MajorTopicYN="N">Traitement décongestif</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>12</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>05</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>5</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24931830</ArticleId>
<ArticleId IdType="pii">S0398-0499(14)00094-8</ArticleId>
<ArticleId IdType="doi">10.1016/j.jmv.2014.05.004</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
<region><li>Languedoc-Roussillon</li>
<li>Occitanie (région administrative)</li>
<li>Île-de-France</li>
</region>
<settlement><li>Montpellier</li>
<li>Paris</li>
<li>cedex 5 Montpellier</li>
</settlement>
<orgName><li>Université Montpellier 1</li>
</orgName>
</list>
<tree><country name="France"><region name="Occitanie (région administrative)"><name sortKey="Quere, I" sort="Quere, I" uniqKey="Quere I" first="I" last="Quéré">I. Quéré</name>
</region>
<name sortKey="Coupe, M" sort="Coupe, M" uniqKey="Coupe M" first="M" last="Coupé">M. Coupé</name>
<name sortKey="Eveno, D" sort="Eveno, D" uniqKey="Eveno D" first="D" last="Eveno">D. Eveno</name>
<name sortKey="Laporte, S" sort="Laporte, S" uniqKey="Laporte S" first="S" last="Laporte">S. Laporte</name>
<name sortKey="Leizorovicz, A" sort="Leizorovicz, A" uniqKey="Leizorovicz A" first="A" last="Leizorovicz">A. Leizorovicz</name>
<name sortKey="Presles, E" sort="Presles, E" uniqKey="Presles E" first="E" last="Presles">E. Presles</name>
<name sortKey="Vaillant, L" sort="Vaillant, L" uniqKey="Vaillant L" first="L" last="Vaillant">L. Vaillant</name>
<name sortKey="Vignes, S" sort="Vignes, S" uniqKey="Vignes S" first="S" last="Vignes">S. Vignes</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006755 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 006755 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:24931830
   |texte=   Prospective multicentre observational study of lymphedema therapy: POLIT study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:24931830" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Prospective multicentre observational study of lymphedema therapy: POLIT study.

Prospective multicentre observational study of lymphedema therapy: POLIT study.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki